The results are surprising but reassuring, says Michael Spencer Chapman, a haematologist at the Barts Cancer Institute in London. It suggests long-term transplant recipients do not have a high risk of cancer-causing mutations.
It's fantastic news for people undergoing these therapies, says Alejo Rodriguez-Fraticelli, emphasizing the significance of the study for enhancing the quality of life for long-term transplant recipients.
The latest study, published in Science Translational Medicine, examined mutations in genes linked to cancer, addressing concerns about whether stem cell transplants could lead to mutation-driven cancers.
Researchers have long worried that transplanting donor stem cells could lead to increased cancer risk, but the findings indicate that most recipients are not facing heightened mutation rates.
Collection
[
|
...
]